Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination

NCT04218409 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT04218409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04218409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination
Lead sponsor
University of Florida
Phase
Phase 1
Overall status
Recruiting
Start date
September 2, 2021
Completion date
December 31, 2026
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain